BioMed Research International

Effects of Microbiota on Cancer Immune Responses and Immunotherapy


Publishing date
01 Sep 2022
Status
Published
Submission deadline
13 May 2022

Lead Editor

1Guangzhou University, Guangzhou, China

2The Research Institute in Oncology and Hematology, Winnipeg, Canada

3McMaster University, Hamilton, Canada

4Universiti Malaysia Sabah, Kota Kinabalu, Malaysia


Effects of Microbiota on Cancer Immune Responses and Immunotherapy

Description

Microbiota collectively refers to all microorganisms living in a defined environment such as on the skin or in the intestinal tract, mouth, vagina, and eyes, including bacteria, archaea, fungi, and viruses. The largest population of microorganisms in the human body locates in the intestine and is called the gut or intestinal microbiota. Intestinal microbes are involved in a variety of physiological functions to maintain the health of the host, including providing nutrients and vitamins, catabolic drugs, and toxins, protecting the body from pathogens, promoting the development of the immune system, and maintaining epithelial mucosal homeostasis. The microbiota plays an important role in the physiology and pathology of the human body.

Cancer is a leading cause of death in the world. According to the World Health Organization (WHO), 10 million people died from cancer in 2020. It is estimated that 10-20% of cancers can be attributed to microbial infections. Many studies have demonstrated that the intestinal microbiota plays an important role in tumorigenesis. Microbes and their products can either have a direct carcinogenic effect or prevent the occurrence and development of cancer by regulating the production of circulating metabolites, inflammation, and immune responses. Cancer immunotherapy is a very promising therapy by boosting the immune system to kill cancer cells and suppress tumor growth. Microbiota on or in the human body can influence immune responses affecting immunotherapy.

This Special Issue invites original research and review articles which contribute to the understanding of the roles of microbiota in cancer immune responses and immunotherapy which may provide novel approaches in treating cancer.

Potential topics include but are not limited to the following:

  • Research and development of microbe-associated cancer immunotherapy
  • Mechanisms of microbiota disturbance in cancer immune responses
  • Correlation of microbiota with tumorigenesis
  • Screening and application of biomarkers of microbiota in cancer immune responses
  • Mechanisms of bacterial translocation causing cancer
  • Relationship between microbiota and mucosal immunity and its anticancer mechanism
  • Signaling pathways of microbiota regulating tumorigenesis
  • Mechanisms and applications of probiotic bacteria in immunotherapy

Articles

  • Special Issue
  • - Volume 2024
  • - Article ID 9846817
  • - Retraction

Retracted: LINC00518 Promotes Cell Malignant Behaviors via Influencing EIF4A3-Mediated mRNA Stability of MITF in Melanoma

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9831386
  • - Retraction

Retracted: Mechanism of Gegen Qinlian Decoction Regulating ABTB1 Expression in Colorectal Cancer Metastasis Based on PI3K/AKT/FOXO1 Pathway

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9826927
  • - Retraction

Retracted: Efficacy of Aidi Injection and Brucea javanica Oil Emulsion Injection in Rectal Cancer during CapeOX Adjuvant Chemotherapy

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9838254
  • - Retraction

Retracted: Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9818941
  • - Retraction

Retracted: The Valuable Role of ARMC1 in Invasive Breast Cancer as a Novel Biomarker

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9786305
  • - Retraction

Retracted: Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9893064
  • - Retraction

Retracted: Correlation of Carotid Artery Intima-Media Thickness with Calcium and Phosphorus Metabolism, Parathyroid Hormone, Microinflammatory State, and Cardiovascular Disease

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9891572
  • - Retraction

Retracted: Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9851737
  • - Retraction

Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma

BioMed Research International
  • Special Issue
  • - Volume 2024
  • - Article ID 9842547
  • - Retraction

Retracted: The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma

BioMed Research International
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.